Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 48 (RPL7P48)

Target
RPL7P48
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L7 pseudogene 48 (RPL7P48) is a non-coding, processed pseudogene derived from the ribosomal protein L7 (RPL7) gene in the human genome[13][2]. Processed pseudogenes are genetic elements that originate from retrotransposition events of functional mRNAs, resulting in DNA sequences that lack introns and typically are not expressed as functional proteins[15]. While functional ribosomal protein L7 plays a structural and regulatory role as part of the ribosomal large subunit, facilitating binding to ribosomal RNA and inhibition of cell-free translation of mRNAs[10], the RPL7P48 pseudogene does not encode a protein and lacks a recognized role in biological processes or pathology. There is no evidence indicating RPL7P48 functions as a therapeutic target or has any drug interactions, biomarker status, or associated safety considerations. RPL7P48 is a pseudogene, not a receptor, enzyme, transporter, or any common drug target. It should not be confused with the functional ribosomal protein L7, which is a bona fide ribosomal protein but is encoded by a different locus[10][13][2].

Other names
RPL7_19_1558RPL7P48[2][13]

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 48 (RPL7P48).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 48 (RPL7P48).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call